This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Telmisartan |
| Description |
Treatment of hypertension and reduction of the risk of MI, stroke, or death from CV causes in patients 55 years and older who are at high risk of developing major CV events. |
| Therapeutic Low |
0.0000 |
| Therapeutic High |
0.0000 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
24.00 |
| Half Life High |
0.00 |
| VOD Low |
0.00 |
| VOD High |
0.00 |
| Toxic Level |
0.000 |
| Lethal Level |
0.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
|